InSyGen Therapeutics Ltd

Focusing on therapeutics for major
health challenges

It is a dilemma for rich countries: as their economies grow they confront more obesity and a type-2 diabetes mellitus epidemic. In the United States, diabetes has increased 40% in ten years. The World Health Organisation estimates that by 2030 the number afflicted worldwide will nearly double to 366 million. As public health campaigns have struggled, attention has turned to genetics to find a response.